Clinical Trial Update: The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating dapagliflozin for efficacy and safety in improving heart failure among dialysis patients (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The People's Hospital of Gaozhou | Conditions: The Efficacy and Safety of Dapagliflozin in Improving Heart Failure in Dialysis Patients | Phase 4 | Status: RECRUITING